AML with KMT2A rearrangements typically shows monocytic or myelomonocytic differentiation [25], with the monoblasts and promonocytes (blast equivalents) having intermediate to high SSC and bright CD33 without CD34. This evidence concerns the gene CD34 and acute myeloid leukemia.